Deep Track Capital, LP - 06 May 2025 SCHEDULE 13G Report for Oruka Therapeutics, Inc. Common Stock, par value $0.001 per share (ORKA)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Oruka Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
ORKA
Shares outstanding
37,411,834 shares
Disclosed Ownership
1,896,780 shares
Ownership
5.1%
Form type
SCHEDULE 13G
Filing time
13 May 2025, 16:32:07 UTC
Date of event
06 May 2025
Next filing
13 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 5.1% 1,896,780 0 1,896,780 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 5.1% 1,896,780 0 1,896,780 /s/ David Kroin David Kroin, Director
David Kroin 5.1% 1,896,780 0 1,896,780 /s/ David Kroin David Kroin